NuVasive (NUVA) Stock Price, News & Analysis

Company Overview

NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal implants to advance spinal fusion by enhancing the osseointegration and biomechanical properties of implant materials, including porous titanium and porous polyetheretherketone; and fixation system that facilitates the preservation and restoration of patient alignment. The company also offers cervical total disc replacement technology for cervical spinal fusion surgery; neuromonitoring systems, which use proprietary software-driven nerve detection and avoidance technology, and its intraoperative neuromonitoring services and support; and Pulse platform, a software ecosystem that integrates multiple hardware technologies into a single, condensed footprint in the operating room. In addition, it provides expandable growing rod implant systems for the treatment of early-onset scoliosis; various biologics that are used to aid in the spinal fusion or bone healing process; Precice, an intramedullary device that utilizes the MAGEC technology to non-invasively lengthen the femur and tibia; and onsite and remote monitoring of the neurological systems of patients undergoing spinal and brain-related surgeries. The company sells its products to patients, surgeons, hospitals, and insurers through independent sales agents, directly employed sales personnel, and distributors in the United States and internationally. NuVasive, Inc. was incorporated in 1997 and is headquartered in San Diego, California. As of September 1, 2023, NuVasive, Inc. operates as a subsidiary of Globus Medical, Inc.

Key Stats

• Today's Range: $39.75 to $39.75
• 50-Day Range: $38.12 to $40.66
• 52-Week Range: $35.17 to $49.53
• Volume: N/A
• Average Volume: 1.16 million shs
• Market Capitalization: $2.08 billion
• P/E Ratio: 79.50
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

NUVA Stock Analysis - Frequently Asked Questions

How were NuVasive's earnings last quarter?

NuVasive, Inc. (NASDAQ:NUVA) posted its earnings results on Wednesday, August, 2nd. The medical device company reported $0.56 earnings per share for the quarter, hitting the consensus estimate of $0.56. The company's revenue for the quarter was up 2.4% on a year-over-year basis.
Read the conference call transcript.

Does NuVasive have any subsidiaries?

NuVasive subsidiaries include Simplify Medical, SafePassage, Vertera Spine, Biotronic NeuroNetwork, Ellipse Technologies, NuVasive Clinical Services Monitoring Inc., NuVasive Japan KK, NuVasive Specialized Orthopedics Inc., and NuVasive Technology International Limited.

What other stocks do shareholders of NuVasive own?

Based on aggregate information from My MarketBeat watchlists, some other companies that NuVasive investors own include Meta Platforms (META), Tesla (TSLA), NVIDIA (NVDA), First Solar (FSLR), Netflix (NFLX), Advanced Micro Devices (AMD) and Home Depot (HD).

Company Calendar

• Last Earnings: 8/02/2023
• Today: 7/18/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Medical Devices
• Sub-Industry: Health Care Equipment
• Current Symbol: NASDAQ:NUVA
• CIK: 1142596
• Web: www.nuvasive.com
• Phone: (858) 909-1800
• Fax: 800-475-9134
• Employees: 3,000
• Year Founded: 1997

Profitability

• EPS (Trailing Twelve Months): $0.50
• Trailing P/E Ratio: 79.50
• Forward P/E Ratio: 17.91
• P/E Growth: N/A
• Net Income: $40.41 million
• Net Margins: 2.32%
• Pretax Margin: 3.41%
• Return on Equity: 12.17%
• Return on Assets: 4.88%

Debt

• Debt-to-Equity Ratio: 0.50
• Current Ratio: 1.25
• Quick Ratio: 0.65

Sales & Book Value

• Annual Sales: $1.23 billion
• Price / Sales: 1.70
• Cash Flow: $4.96 per share
• Price / Cash Flow: 8.01
• Book Value: $17.02 per share
• Price / Book: 2.34

Miscellaneous

• Outstanding Shares: 52,449,000
• Free Float: 52,171,000
• Market Cap: $2.08 billion
• Optionable: Optionable
• Beta: 1.07